BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Takeda Steps Back from Cell & Gene Therapy to Refocus on Predictable Growth

Takeda Pharmaceutical, one of the world’s most globalised pharma companies, has confirmed it will step away from in-house development of its cell and...

October 05, 2025 | News

The $100 Billion Question: Can India Lead the Global Diabetes Economy?

India’s Diabetes Burden and Global Stakes: India is often called the “diabetes capital of the world,” and not without reason. Recent esti...

September 24, 2025 | Analysis | By editor@biopharmaapac.com

Could Early Lifestyle Interventions Change the Course of Type 2 Diabetes?

According to the Centers for Disease Control and Prevention (CDC), over 38 million Americans have diabetes. Of these, around 90% to 95% have Type 2 diabete...

September 18, 2025 | News

The State of Biotech and Life Science Jobs in Asia Pacific – 2025

In 2025, Asia-Pacific has emerged as the fastest-growing hub for biotech and life sciences employment, fuelled by a powerful combination of government supp...

September 09, 2025 | Report

Antengene Reports Strong H1 2025 Results with Breakthrough Therapy Designation for ATG-022 and Robust Pipeline Progress

The Phase I/II CLINCH study of ATG-022 (CLDN18.2 antibody-drug conjugate) demonstrated promising results, showing robust clinical efficacy and a fav...

August 25, 2025 | Company results

China’s Biopharma Dealmaking Surges in H1 2025, Driven by Record Licensing and Oncology Focus

The first seven months of 2025 saw robust dealmaking in China’s biopharma and healthcare sector, even as global headwinds tempered some activity. Chi...

August 15, 2025 | Report

“Spatial Biology at Scale: 10x Genomics CEO Serge Saxonov on Redefining Precision Medicine with TISHUMAP”

The future of medicine is being shaped at the intersection of spatial biology and artificial intelligence—and 10x Genomics is l...

August 07, 2025 | Interaction

Precision Medicine – Are We Ready for It?

Sarthak Ranade, Area Managing Director of Johnson & Johnson Innovative Medicine for SEA and India, believes the era of precision medicine is no longer ...

July 23, 2025 | Opinion | By Sarthak Ranade, Area Managing Director, J&J Innovative Medicine, SEA & India

BioPharma in APAC: Mid-Year Report 2025 – Tracking Progress, Trends & Possibilities Ahead

As we cross the midpoint of 2025, BioPharma APAC presents this Mid-Year Report—an incisive look at emerging biopharmaceutical dynamics, key i...

July 21, 2025 | Analysis

Unlocking Solubility as Lubrizol's Excipients Power the Next Generation of Drug Delivery

With up to 90% of new chemical entities suffering from poor water solubility, pharmaceutical innovators are under pressure to reformulate for eff...

July 09, 2025 | Interview

Smarter Together: How Molecule GEN Transforms Cross-Functional Drug Discovery

This cloud-native, SaaS-based platform breaks down traditional barriers in drug discovery by uniting all disciplines—biology, chemistry, and computat...

July 07, 2025 | Opinion | By Saurabh Singal | CEO-Founder, Molecule AI

Closer to Customers, Stronger in Supply: Oliver’s APAC Leader on Malaysia Facility and Future Plans

In a move that underscores its long-term commitment to the Asia-Pacific region, Oliver Healthcare Packaging has inaugurated a new...

May 23, 2025 | Interview

Bridging the Vision Gap: Roche’s Ahmed Elhusseiny on Eye Health Priorities in Asia Pacific

Vision health is emerging as a critical but under-addressed component of public health in Asia Pacific. In a region where populations are rapidly ageing an...

May 09, 2025 | Expert Insight

ACG Leads the Charge in Vegan Capsules: Innovation, Certification, and the Future of Sustainable Pharma

As the demand for plant-based and clean-label pharmaceutical solutions grows, ACG Capsules has positioned itself at the forefront of innovation with its ve...

March 06, 2025 | Interview

Stay Connected